top of page


Revolutionizing arthritis treatment with our organ-on-a-chip platform (Optimate OA™)

At Pregenerate GmbH, we use scaleable organ-on-a-chip models to understand how cartilage cells respond to inflammation and to different treatments, in a life-like way. This technology will ultimately allow us to stratify patients into targeted treatment subgroups, and even to tell each clinical patient what the best treatment is for his or her specific arthritis needs directly. Our device is also poised to save  pharmaceutical companies billions of dollars and improve the success rates of their drugs to market, in part because we can use human cells to replace animal testing in pharmaceutical research for arthritis treatments.

Pregenerate Team Picture
pregenerat site
Watch Now
bottom of page